Century Therapeutics (IPSC) Income Statement (2020 - 2026)
Income Statement report data from Mar 31, 2020 to Mar 31, 2026 for Century Therapeutics (IPSC).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | |||||||||||||||||||||||||
Total Revenue | - | - | - | - | 109M (+2517.75%) | 4.17M (+427.85%) | 790K (+2.60%) | 770K (-10.47%) | 860K (+218.52%) | 270K (+80.00%) | 150K (+50.00%) | 100K (-94.19%) | 1.72M (+230.77%) | 520K (-76.58%) | 2.22M (+58.57%) | 1.40M (+32.08%) | 1.06M | - | - | - | - | - | - | - | - |
Operating Expenses | |||||||||||||||||||||||||
Research And Development | 17M (-59.47%) | 42M (+422100.00%) | 10K (-99.96%) | 27M (+1.05%) | 27M (-9.53%) | 29M (+7.90%) | 27M (+0.04%) | 27M (+16.23%) | 23M (+5.02%) | 22M (-2.15%) | 23M (+0.26%) | 23M (-8.71%) | 25M (-2.70%) | 26M (-1.20%) | 26M (+5.76%) | 24M (+15.52%) | 21M (-2.75%) | 22M (+11.51%) | 20M (+3.28%) | 19M (+23.16%) | 15M (-24.62%) | 20M (+88.62%) | 11M (+27.48%) | 8.48M | - |
Selling General And Administrative | 6.58M (+585.42%) | 960K (-85.96%) | 6.84M (-12.42%) | 7.81M (-7.13%) | 8.41M (+8.52%) | 7.75M (-7.19%) | 8.35M (+0.48%) | 8.31M (-4.92%) | 8.74M (+1.75%) | 8.59M (-4.45%) | 8.99M (+9.23%) | 8.23M (-7.53%) | 8.90M (+8.01%) | 8.24M (+2.23%) | 8.06M (-2.30%) | 8.25M (+13.01%) | 7.30M (+18.12%) | 6.18M (-1.59%) | 6.28M (+53.55%) | 4.09M (+52.04%) | 2.69M (-44.76%) | 4.87M (+109.91%) | 2.32M (+0.43%) | 2.31M | - |
Operating Expenses | 24M (+14.62%) | 21M (-42.80%) | 36M (+4.21%) | 35M (-0.94%) | 35M (-15.61%) | 41M (+16.53%) | 36M (+0.14%) | 36M (+10.48%) | 32M (-26.96%) | 44M (+23.09%) | 36M (+1.68%) | 35M (+4.08%) | 34M (-0.09%) | 34M (-0.38%) | 34M (+3.69%) | 33M (-14.91%) | 38M (+37.61%) | 28M (+8.28%) | 26M (+12.21%) | 23M (+27.46%) | 18M (-28.48%) | 25M (+92.31%) | 13M (-15.40%) | 16M | - |
Depreciation And Amortization | 3.00M (-15.49%) | 3.55M (+13.42%) | 3.13M (-2.19%) | 3.20M (-0.62%) | 3.22M (-3.01%) | 3.32M (+0.61%) | 3.30M (-4.62%) | 3.46M (+7.12%) | 3.23M (-9.01%) | 3.55M (+5.97%) | 3.35M (+3.72%) | 3.23M (+11.00%) | 2.91M (+2.46%) | 2.84M (+2.53%) | 2.77M (+65.87%) | 1.67M (+43.97%) | 1.16M (+10.48%) | 1.05M (+0.96%) | 1.04M (+10.64%) | 940K (+30.56%) | 720K (+1.41%) | 710K (+73.17%) | 410K (+46.43%) | 280K | - |
Operating Income | |||||||||||||||||||||||||
Operating Income | -23.68M (+14.62%) | -20.66M (-42.80%) | -36.12M (+4.21%) | -34.66M | 74M | -37.28M (+7.16%) | -34.79M (+0.09%) | -34.76M (+11.02%) | -31.31M (-28.45%) | -43.76M (+22.82%) | -35.63M (+1.57%) | -35.08M (+9.35%) | -32.08M (-3.69%) | -33.31M (+4.95%) | -31.74M (+1.24%) | -31.35M (-16.27%) | -37.44M (+33.86%) | -27.97M (+8.28%) | -25.83M (+12.21%) | -23.02M (+27.46%) | -18.06M (-28.48%) | -25.25M (+92.31%) | -13.13M (-15.40%) | -15.52M | - |
Ebit | -23.68M (+14.62%) | -20.66M (-42.80%) | -36.12M (+4.21%) | -34.66M | 74M | -37.28M (+7.16%) | -34.79M (+0.09%) | -34.76M (+11.02%) | -31.31M (-28.45%) | -43.76M (+22.82%) | -35.63M (+1.57%) | -35.08M (+9.35%) | -32.08M (-3.69%) | -33.31M (+4.95%) | -31.74M (+1.24%) | -31.35M (-16.27%) | -37.44M (+33.86%) | -27.97M (+8.28%) | -25.83M (+12.21%) | -23.02M (+27.46%) | -18.06M (+15.92%) | -15.58M (+18.66%) | -13.13M (-15.40%) | -15.52M (+60.50%) | -9.67M |
EBITDA | -20.68M (+20.86%) | -17.11M (-48.14%) | -32.99M (+4.86%) | -31.46M | 77M | -33.97M (+7.88%) | -31.49M (+0.64%) | -31.29M (+11.43%) | -28.08M (-30.17%) | -40.21M (+24.57%) | -32.28M (+1.38%) | -31.84M (+9.15%) | -29.17M (-4.27%) | -30.47M (+5.21%) | -28.96M (-2.43%) | -29.68M (-18.19%) | -36.28M (+34.77%) | -26.92M (+8.64%) | -24.78M (+12.18%) | -22.09M (+27.39%) | -17.34M (+16.61%) | -14.87M (+16.90%) | -12.72M (-16.48%) | -15.23M (+57.50%) | -9.67M |
Other Income / Expenses | |||||||||||||||||||||||||
Interest Expense | - | - | - | - | - | - | - | - | - | - | - | 140K (-65.00%) | 400K | - | 370K (+12.12%) | 330K (+6.45%) | 310K (-3.13%) | 320K (0.00%) | 320K (0.00%) | 320K (+3.23%) | 310K (-3.13%) | 320K (+433.33%) | 60K | - | - |
Net Interest Income | - | - | - | - | - | - | - | - | - | - | - | -140.00K (-65.00%) | -400.00K | - | -370.00K (+12.12%) | -330.00K (+6.45%) | -310.00K (-3.13%) | -320.00K (0.00%) | -320.00K (0.00%) | -320.00K (+3.23%) | -310.00K (-3.13%) | -320.00K (+433.33%) | -60.00K | - | - |
Other Non Operating Income | 20K (-92.86%) | 280K (+180.00%) | 100K (-9.09%) | 110K | -40.00K | 350K (+40.00%) | 250K | -10.00K | 10K | -380.00K | 10K | -190.00K (0.00%) | -190.00K | 2.99M | -20.00K | 10K | -60.00K (-93.33%) | -900.00K (+400.00%) | -180.00K (-28.00%) | -250.00K (-13.79%) | -290.00K | 320K (+166.67%) | 120K (-45.45%) | 220K | - |
Net Income | |||||||||||||||||||||||||
Income Before Tax | - | -19.24M (-44.10%) | -34.42M (+5.78%) | -32.54M | 77M | -34.30M (+9.83%) | -31.23M (+0.16%) | -31.18M (+11.12%) | -28.06M (-30.32%) | -40.27M (+25.33%) | -32.13M (-0.65%) | -32.34M (+7.58%) | -30.06M (-5.02%) | -31.65M (+3.03%) | -30.72M (-0.81%) | -30.97M (-17.41%) | -37.50M (+33.21%) | -28.15M (+8.23%) | -26.01M (+11.77%) | -23.27M (+26.81%) | -18.35M (-65.75%) | -53.57M | - | - | - |
Income Tax Expense | - | -70.00K | - | - | - | 1.78M | -10.00K | 20K | - | -870.00K | 590K (-37.89%) | 950K (-21.49%) | 1.21M (+3933.33%) | 30K (0.00%) | 30K (+50.00%) | 20K (0.00%) | 20K (-50.00%) | 40K | - | - | - | - | - | - | - |
Net Income From Continuing Operations | -21.64M (+12.83%) | -19.18M (-44.28%) | -34.42M (+5.78%) | -32.54M | 77M | -36.07M (+15.50%) | -31.23M (+0.06%) | -31.21M (+11.23%) | -28.06M (-28.78%) | -39.40M (+20.42%) | -32.72M (-1.71%) | -33.29M (+6.49%) | -31.26M (-1.33%) | -31.68M (+3.02%) | -30.75M (-0.77%) | -30.99M (-17.38%) | -37.51M (+33.06%) | -28.19M (+8.38%) | -26.01M (+11.77%) | -23.27M (+26.81%) | -18.35M (+18.16%) | -15.53M (+18.82%) | -13.07M (-14.58%) | -15.30M (+58.22%) | -9.67M |
Net Income | -21.64M (+12.83%) | -19.18M (-44.28%) | -34.42M (+5.78%) | -32.54M | 77M | -36.07M (+15.50%) | -31.23M (+0.06%) | -31.21M (+11.23%) | -28.06M (-28.78%) | -39.40M (+20.42%) | -32.72M (-1.71%) | -33.29M (+6.49%) | -31.26M (-1.33%) | -31.68M (+3.02%) | -30.75M (-0.77%) | -30.99M (-17.38%) | -37.51M (+33.06%) | -28.19M (+8.38%) | -26.01M (+11.77%) | -23.27M (+26.81%) | -18.35M (+18.16%) | -15.53M (+18.82%) | -13.07M (-14.58%) | -15.30M (+58.22%) | -9.67M |
Comprehensive Income Net Of Tax | -22.26M (+125.53%) | -9.87M (-71.34%) | -34.44M (+5.13%) | -32.76M | 77M | -126.35M (+318.93%) | -30.16M (-3.55%) | -31.27M (+10.07%) | -28.41M (-78.81%) | -134.10M (+308.59%) | -32.82M (-1.20%) | -33.22M (+10.44%) | -30.08M (-77.34%) | -132.74M (+329.30%) | -30.92M (-2.71%) | -31.78M (-19.56%) | -39.51M (-59.04%) | -96.47M (+270.04%) | -26.07M (+12.13%) | -23.25M (+26.57%) | -18.37M (-65.71%) | -53.57M (+307.38%) | -13.15M (-13.49%) | -15.20M | - |